Soap, water, 20 seconds
Noom appears to be legitimate, but its medical weaknesses include limited provider follow-up, incomplete pharmacy transparency, reliance on compounded products in some plans, and no required live visit or lab work
The entire GLP-1 supplement category operates in a gray zone between legitimate metabolic support and misleading claims
The market size of GLP-1 Receptor Agonist market is expected to register compound annual growth rate (CAGR) of 21.7% over the forecast period
Step 4: Track, Track, Track Did I take my dose today
This genetic roadmap helps PlexusDx clinicians determine whether semaglutide injection, tirzepatide injection, oral formulations, the Microdose GLP-1 Protocol ($129/mo), or GLP-Squared combinations are most appropriate for your weight loss goals